Labcorp Holdings (LH) Non-Current Deferred Tax Liability (2009 - 2026)
Labcorp Holdings' (LH) quarterly Non-Current Deferred Tax Liability came in at $456.4 million in Q1 2026, up 17.63% year-on-year from $388.0 million in Q1 2025, and little changed quarter-over-quarter from $454.5 million in Q4 2025.
Labcorp Holdings (LH) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
Labcorp Holdings has disclosed Non-Current Deferred Tax Liability across 18 years of filings, most recently posting $456.4 million for Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $456.4 million, up 17.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $456.4 million (up 17.63% YoY), and the FY2025 annual result was $454.5 million, up 18.64% from the prior year.
- Non-Current Deferred Tax Liability came in at $456.4 million for Q1 2026 at Labcorp Holdings, roughly flat from $454.5 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $765.2 million in Q1 2022 to a low of $354.5 million in Q2 2025.
- The 5-year median for Non-Current Deferred Tax Liability is $454.5 million (2025), against an average of $503.2 million.
- Across the five-year window, Non-Current Deferred Tax Liability tumbled 46.14% in 2024 and grew 23.22% in 2025, its largest moves.
- Labcorp Holdings' Non-Current Deferred Tax Liability stood at $543.4 million in 2022, then decreased by 23.1% to $417.9 million in 2023, then dropped by 8.33% to $383.1 million in 2024, then advanced by 18.64% to $454.5 million in 2025, then increased by 0.42% to $456.4 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $456.4 million (Q1 2026), $454.5 million (Q4 2025), and $441.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Labcorp Holdings | 22.31 Bn | 21.34 Bn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 456.40 Mn |
| Mar 31, 2026 | 456.40 Mn |
| Dec 31, 2025 | 454.50 Mn |
| Dec 31, 2025 | 454.50 Mn |
| Sep 30, 2025 | 441.50 Mn |
| Sep 30, 2025 | 441.50 Mn |
| Jun 30, 2025 | 354.50 Mn |
| Jun 30, 2025 | 354.50 Mn |
| Mar 31, 2025 | 388.00 Mn |
| Mar 31, 2025 | 388.00 Mn |
| Dec 31, 2024 | 383.10 Mn |
| Dec 31, 2024 | 383.10 Mn |
| Sep 30, 2024 | 358.30 Mn |
| Sep 30, 2024 | 358.30 Mn |
| Jun 30, 2024 | 376.10 Mn |
| Jun 30, 2024 | 376.10 Mn |
| Mar 31, 2024 | 397.20 Mn |
| Mar 31, 2024 | 397.20 Mn |
| Dec 31, 2023 | 417.90 Mn |
| Dec 31, 2023 | 417.90 Mn |